"None of the parties are accused of selling stock. ".....
Ummm...Yes, they are.
"In 2013 and 2015, Nutra Pharma raised over $920,000 by issuing millions of shares of its stock to over thirty investors in at least two private placement offerings, for which Nutra Pharma failed to file required registration statements with the Commission."
Deitsch allegedly engaged in manipulative trading designed to "walk up" Nutra Pharma's stock price and create the appearance of active trading in Nutra Pharma. Further, Nutra Pharma and Deitsch allegedly failed to make numerous required filings, including filings about the company's sales of unregistered securities and filings about Deitsch's beneficial ownership of the company's securities. According to the SEC's complaint, Sean McManus, a consultant for Nutra Pharma, also made numerous misstatements while soliciting investors in Nutra Pharma. In addition, McManus allegedly acted as an unregistered broker, despite being permanently barred in 2001 by the NASD (now FINRA) from associating with NASD member firms.